Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on March 29, 2017. The filing serves as a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. The document primarily acts as a cover for a press release dated March 29, 2017, included as Exhibit 99.1.
Financial Metrics
The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The filing text does not provide a clear value for any financial metric.
Material Changes
The filing text does not provide information regarding material changes versus prior comparable periods. The content is limited to the cover page and exhibit index.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in the provided text. The filing references a press release (Exhibit 99.1) which likely contains these details, but the text of that release is not included in the input.
Key Facts for Investor Verification
- Verify the content of the press release dated March 29, 2017 (Exhibit 99.1), as the Form 6-K itself contains no substantive operational or financial data.
- Confirm the company's status as a registrant filing under Form 20-F.
- Note that the Chief Executive Officer, André Choulika, signed the report on behalf of the registrant.